« Providence police officer indicted on rape charge | Today | Affidavit reveals details behind Freddie Bishop's arrest »

August 1, 2007

Amgen vice president of operations leaving company

WEST GREENWICH -- Dennis Fenton, the executive vice president of operations for Amgen Inc., is leaving the company, Amgen announced today.

Fenton, 55, has worked at Amgen for 25 years. He will leave the company at the end of the year.

In an interview with The Providence Journal in May, Fenton praised Amgen's manufacturing facility in West Greenwich, where the company employs 1,700 people to produce the drug Enbrel. If sales of Enbrel were to decline, Fenton said in the interview, Amgen would continue to operate the plant.

"We're looking at other uses for the facility," he said. "It's been a great site."

After years of strong sales and a soaring stock price, Amgen recently hit a rough patch when studies raised questions about the effectiveness of some uses of Amgen's highly profitable anemia drugs, Aranesp and Epogen.

The company, based in Thousand Oaks, Calif., said today that Fabrizio Bonanni, senior vice president of manufacturing, will succeed Fenton.

-- Journal staff writer Benjamin N. Gedan

Posted by Mike McKinney  at 6:16 PM | Permalink

Comments

Post a comment

Please be civil. Vicious comments, personal attacks and profanity won't be published. Name and email are required; email address will not publish.

Name:

Email Address:

URL:
Remember Me? YesNo

Comments: (you may use HTML tags for style)